AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 182 filers reported holding AXSOME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,248,515 | -57.4% | 17,864 | -56.2% | 0.00% | 0.0% |
| Q2 2023 | $2,930,450 | +43.1% | 40,780 | +22.9% | 0.00% | +50.0% |
| Q1 2023 | $2,047,160 | +52.3% | 33,190 | +90.5% | 0.00% | -60.0% |
| Q4 2022 | $1,343,759 | +55.9% | 17,422 | -9.8% | 0.01% | +150.0% |
| Q3 2022 | $862,000 | +5.1% | 19,323 | -9.7% | 0.00% | 0.0% |
| Q2 2022 | $820,000 | -2.3% | 21,401 | +5.5% | 0.00% | 0.0% |
| Q1 2022 | $839,000 | +9.5% | 20,282 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $766,000 | +18.2% | 20,282 | +3.1% | 0.00% | 0.0% |
| Q3 2021 | $648,000 | -51.2% | 19,670 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $1,327,000 | +19.1% | 19,670 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $1,114,000 | -14.4% | 19,670 | +23.1% | 0.00% | 0.0% |
| Q4 2020 | $1,302,000 | +44.3% | 15,983 | +26.2% | 0.00% | 0.0% |
| Q3 2020 | $902,000 | – | 12,666 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,009,799 | $82,268,000 | 41.24% |
| Fairmount Funds Management LLC | 220,098 | $17,931,000 | 6.41% |
| WMS Partners, LLC | 250,000 | $20,368,000 | 3.51% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,064,158 | $168,167,000 | 3.06% |
| MORGAN JESS S & CO INC | 44,468 | $3,623,000 | 2.88% |
| RTW INVESTMENTS, LP | 1,672,416 | $136,252,000 | 2.29% |
| RA Capital Management | 1,655,447 | $134,869,000 | 1.88% |
| Nicholas Investment Partners, LP | 207,452 | $16,901,000 | 1.30% |
| Affinity Asset Advisors, LLC | 25,000 | $2,037,000 | 1.08% |
| Parkman Healthcare Partners LLC | 30,758 | $2,506,000 | 0.64% |